The self-renewal and quiescence of hematopoietic stem cells (HSCs) are controlled by a highly orchestrated integration of environmental signals, most of which originate from the stem cell niche 1,2 . Long-term HSCs (LT-HSCs) reside at the top of the developmental pyramid, as they are able to self-renew and sustain hematopoiesis 3 . This fraction of HSCs remains largely quiescent or even dormant throughout the lifetime of an organism. Cells that receive differentiation-promoting niche signals are able to generate multipotent progenitors (MPPs), which are cells with diminished self-renewal that can enter further differentiation routes that will lead them to generate progenitors of the myeloerythroid or lymphoid lineages.
A r t i c l e s
The self-renewal and quiescence of hematopoietic stem cells (HSCs) are controlled by a highly orchestrated integration of environmental signals, most of which originate from the stem cell niche 1, 2 . Long-term HSCs (LT-HSCs) reside at the top of the developmental pyramid, as they are able to self-renew and sustain hematopoiesis 3 . This fraction of HSCs remains largely quiescent or even dormant throughout the lifetime of an organism. Cells that receive differentiation-promoting niche signals are able to generate multipotent progenitors (MPPs), which are cells with diminished self-renewal that can enter further differentiation routes that will lead them to generate progenitors of the myeloerythroid or lymphoid lineages.
Intense experimentation during the past two decades has suggested that tight control of HSC differentiation is controlled by the interaction of a handful genetic and epigenetic regulators of gene transcription 4, 5 . However, transcriptional control will probably not provide the complete answer to the puzzle of stem cell differentiation. We suggest here that post-transcriptional or even post-translational regulation has an essential role. The emergence of microRNA function in both embryonic and adult stem cell biology is one example 6 . Another emerging paradigm of post-translational modification is mono-or polyubiquitination of protein substrates, leading to alteration of target half-life or modification of activation status. Ubiquitination is performed by large enzymatic complexes that include ubiquitinactivating and ubiquitin-conjugating components, as well as adaptors that dictate substrate specificity 7, 8 . One of the most important and well-characterized outcomes of protein ubiquitination is targeting to and subsequent degradation by the proteasome. By controlling protein stability and abundance, ubiquitin ligases regulate distinct biological processes, including cell-cycle entry and progression 9 .
Published studies have suggested that ubiquitination, proteosomal degradation and protein stability could also control stem cell function in different organisms [10] [11] [12] [13] . These studies introduced the hypothesis that fine tuning of the half-life, stability and abundance of key regulators by the ubiquitin-proteasome machinery could control HSC function, specifically, self-renewal and differentiation. Testing this hypothesis in vivo is a challenging task, as it requires quantitative assessment of substrate abundance in small stem cell and progenitor subsets. To overcome this limitation, we have used gene-targeted mice in which relative protein abundance can be studied in vivo by flow cytometry and microscopy. As a model ubiquitin substrate, we selected the transcription factor c-Myc, a well-known oncogene and developmental regulator 14, 15 . The expression and function of c-Myc are important for HSC differentiation and, more specifically, for the survival of HSCs and their retention in the niche 16, 17 . However, the molecular mechanism by which c-Myc controls HSC function is largely unknown. For example, similar amounts of Myc mRNA are detected in HSCs and differentiated progenitors 16 . That finding introduces the hypothesis that the functions of c-Myc in stem and progenitor cells are more likely controlled posttranslationally than at the level of transcription. Moreover, several studies have shown that the stability of c-Myc protein is controlled by the ubiquitin system. At least three distinct E3 ligases (Skp2, Huwe1 and Fbw7) [18] [19] [20] are involved in its regulation.
We demonstrate here that the abundance of nuclear c-Myc protein was indicative of HSC quiescence and self-renewal status, and c-Myc stability in HSC was controlled by a single E3 ubiquitin ligase, Fbw7. Deletion of the gene encoding Fbw7 (Fbxw7; called Fbw7 here) led to overexpression of c-Myc protein in single HSCs, and lower c-Myc abundance 'rescued' the Fbw7 −/− HSC phenotype. Moreover, we demonstrate that the HSC gene-expression signature was controlled by fine changes in the stability of c-Myc protein and identify specific gene regulators of HSC quiescence and self-renewal. Wholegenome chromatin immunoprecipitation (ChIP) experiments identified genes directly regulated by the binding of c-Myc to their promoter and c-Myc transcriptional activity. Finally, we contrast adult HSCs with in vitro self-renewing embryonic stem cells (ESCs). We demonstrate that each stem cell type was able to sense and interpret c-Myc abundance and c-Myc-regulated gene expression in distinct ways. Our studies offer an example of a ubiquitin ligase-substrate pair able to orchestrate the molecular program of the differentiation of adult mammalian stem cells.
RESULTS

Abundance of c-Myc protein in single HSCs and progenitors
To visualize c-Myc protein abundance in vivo, we took advantage of a published animal model in which an enhanced green fluorescent protein (eGFP) reporter replaces the start codon of Myc in the second exon in the Myc locus (Myc eGFP ), which generates a functional c-Myc protein with an amino-terminal tag that faithfully mirrors the expression of endogenous protein 21 . Homozygous Myc eGFP/eGFP mice were viable, with no alterations in the kinetics of hematopoietic differentiation or immune function. We found that c-Myc-eGFP was not expressed in lineage-positive (Lin + ), mature bone marrow cells, but its expression became evident when we focused on Lin − progenitors (Fig. 1a-c) . We detected the highest expression of c-Myc (c-Myc-eGFP) in the myeloerythroid progenitor fraction, a cell population that originates directly from Lin − Sca-1 + c-Kit + (LSK) cells and is actively proliferating. To further confirm the faithful expression of the c-Myc-eGFP fusion, we purified wild-type Lin − c-Kit + progenitors and Lin + cells from whole bone marrow. Endogenous c-Myc protein was expressed only in the progenitor fraction (Fig. 1c) . These experiments showed that c-Myc protein expression was detectable in the LSK fraction and peaked at the myeloerythroid progenitor stage in adult bone marrow.
Correlation of c-Myc protein with HSC differentiation
We noticed that LSK cells, a population containing HSCs and multipotential progenitors, included both a c-Myc-eGFP + fraction and a c-Myc-eGFP − fraction (Fig. 1d) . HSCs differentiate through intermediate stages, generating at least two subsets of multipotential progenitors (MPP1 and MPP2) 22 . Only LT-HSCs have the ability to selfrenew and are largely quiescent or even dormant 22 . Therefore, we subdivided the LSK fraction using both signaling lymphocytic-activation molecule markers (CD150 and CD48; Fig. 1e and Supplementary  Fig. 1 ) and the cytokine receptor Flt3 plus CD34 (data not shown). Much higher c-Myc protein expression (Fig. 1e) correlated perfectly with differentiation stage, as LT-HSCs were almost exclusively c-Myc-eGFP − (>95%), whereas the MPP1 fraction was the first subset with detectable c-Myc protein and there were further increases in c-Myc protein abundance in more differentiated CD150 − CD48 + 
L T Myc expression (fold)
Fbw7 expression (fold) A r t i c l e s MPP2 cells. To determine whether the c-Myc expression changes we observed were independent of transcriptional control, we compared Myc mRNA expression in the various populations. Myc transcription did not increase as LT-HSCs differentiated (Fig. 1f) , which suggested that the protein changes we identified were due mainly to posttranscriptional mechanisms. These data connect relative c-Myc protein abundance to specific stages of HSC differentiation.
Effects of extrinsic stress signals on c-Myc expression
We then sought to determine whether environmental cues such as stress or tissue injury could feed back on LSK cell proliferation and c-Myc protein abundance. Initially, we discovered that the abundance of c-Myc protein not only was suggestive of the differentiation stage but also dictated cell-cycle status. Indeed, c-Myc-eGFP lo LSK cells were exclusively in the G0-G1 phases and c-Myc-eGFP hi cells were actively cycling (Fig. 1g) . Moreover, as tissue injury can induce the exit of HSCs from quiescence, we used the chemotherapeutic agent 5-fluorouracil (5-FU) to induce myeloablation, a process that normally activates quiescent HSCs 23 . Consistent with that idea, two-to threefold more LSK cells from 5-FU-treated Myc eGFP/+ mice had entered cell cycle 2 d after treatment than cells from untreated control mice. Most notably, these cells purified from 5-FU-treated mice had substantially more c-Myc protein (Supplementary Fig. 2 ). These experiments show that extrinsic stress signals can affect c-Myc protein expression in primitive hematopoietic progenitors, which illustrates feedback regulation.
Prediction of self-renewal status by c-Myc protein expression
The observations reported above suggested that c-Myc protein abundance (but not Myc mRNA) could dictate the potential of HSCs to self-renew and influence their ability to differentiate. To test this hypothesis, we used fluorescence-activated cell sorting to divide the LSK population into c-Myc-eGFP hi and c-Myc-eGFP lo cells (Fig. 2a) . To achieve an estimate of the differentiation capacity of these two populations, we used colony-forming unit assays, seeding each subset on cytokine-supplemented methylcellulose media. The first plating showed that the c-Myc-eGFP hi fraction had a two-to threefold greater capacity to generate colonies; however, replating of the sorted c-Myc-eGFP hi LSK cells yielded a total inability to form colonies, reflecting a putative loss of in vitro self-renewing capacity. In contrast, the c-Myc-eGFP lo population efficiently generated colonies after the first replating, retaining characteristics of true self-renewing HSCs (Fig. 2b) . To support those observations with in vivo studies, we did competitive reconstitution with 1,000 LSK cells purified from both fractions (expressing the marker CD45.2). In agreement with the in vitro studies, c-Myc-eGFP lo cells were able to efficiently compete with (50:50) and generate all mature lineages as well as stem and progenitor cells 25 weeks after transplantation ( Fig. 2c,d ). In contrast, c-Myc-eGFP hi cells were less efficient in generating long-term chimerism (6-10% as efficient as the c-Myc-eGFP lo population; Fig. 2c,d ), which suggested that this population was largely devoid of LT-HSC activity. A published study has suggested that aging could affect the differentiation ability of HSCs because of aberrant DNA repair 24 . As all the experiments described above used mice 6-10 weeks of age, we sought to determine whether the c-Myc-dependent regulation of HSC self-renewal is a central control mechanism in HSCs from adult mice independently of HSC age. We repeated these experiments with aged HSCs (from mice >60 weeks old). We found that old and young HSCs demonstrated identical c-Myc-eGFP profiles ( Supplementary Fig. 3a ).
Colony assays and bone marrow-transplantation assays further proved that the relative abundance of c-Myc protein dictated the long-term reconstitution ability of LSK cells ( Supplementary Fig. 3b and data not shown). These findings support the idea that the abundance of c-Myc protein expression can be used to predict the HSC stage and that after c-Myc protein stabilization, HSCs lose their ability to self-renew.
Fbw7 regulates c-Myc protein abundance in adult HSCs
The observations reported above suggested that c-Myc-regulated self-renewal of HSCs from adults could be controlled by a posttranscriptional and probably a post-translational mechanism of regulation. To start probing this hypothesis, we studied the expression pattern of three enzymes, members of the ubiquitin-proteasome system that have been suggested to be putative regulators of c-Myc protein stability (Huwe1, Skp2 and Fbw7) 25 . One of these, Fbw7, demonstrated a gene-expression pattern reciprocal to that of c-Myc-eGFP protein expression (Fig. 1f) . To further determine whether Fbw7 controls the stability of c-Myc protein in HSCs, we generated Mx1-Cre + Fbw7 flox/flox Myc eGFP/eGFP mice. Mx1 has a type I interferon-inducible promoter 26 that can be activated by intraperitoneal injection of polyinosinic-polycytidylic acid (poly(I:C)), resulting in inducible expression of Cre recombinase and subsequent deletion (Fig. 3a) . More notably, c-Myc protein was more stable in the LT-HSC compartment, as defined by the signaling lymphocytic-activation molecule markers CD150 and CD48, after deletion of Fbw7 (Fig. 3b) . Such stabilization was also evident in both the myeloerythroid progenitor subset and in thymic CD4 − CD8 − double-negative (DN) T cell progenitors. Moreover, there were no substantial differences between the different genotypes in the abundance of Myc mRNA expression (data not shown). Thus, these data provide in vivo support for the idea of an interaction between c-Myc protein stability and Fbw7 enzymatic function in HSCs.
Decrease in c-Myc rescues Fbw7 −/− HSC phenotypes
To further prove the relevance of c-Myc stabilization to Fbw7 −/− LSK cells, we attempted to rescue the Fbw7 deficiency-induced HSC phenotype by decreasing c-Myc protein expression 14 . As total c-Myc deficiency completely abrogates HSC differentiation 16, 17 , we generated Fbw7 −/− LSK cells lacking a single copy of c-Myc (Mx1-Cre + Fbw7 flox/flox Myc flox/+ ). Deletion of a single Myc allele restored LSK numbers, cell-cycle status and in vitro self-renewal capacity ( Fig. 3c-e) . The combined data (Figs. 2 and 3) suggested that c-Myc protein stability in HSCs is controlled mainly by the activity of the Fbw7 ligase. These results are consistent with studies unable to detect stabilization of additional Fbw7 substrates (Notch1 and Notch3, c-Jun and cyclin E) in Fbw7 −/− hematopoietic progenitors 12 (data not shown).
The Fbw7-c-Myc interaction controls LT-HSC differentiation
The observations reported above led us to predict that Fbw7 deletion should result in lower absolute LT-HSC numbers and, conversely, the Myc deletion should, at least phenotypically, expand the HSC subset.
To test our hypothesis, we initially induced Fbw7 deletion using the Mx1-Cre model (Mx1-Cre + Fbw7 flox/flox mice). Deletion of Fbw7 rapidly led to substantially lower LSK frequency ( Supplementary  Fig. 4a ). Likewise, in the LSK subset, there was an obvious lower frequency and total cell number of the CD150 + CD48 − LT-HSC subset ( Supplementary Fig. 4b,c) , which suggested that deletion of Fbw7 promoted the developmental transition from LT-HSC to MPP and explained the loss of LT-HSCs activity observed in Fbw7 −/− mice. In contrast, inducible deletion of Myc led to an opposite phenotype characterized by the accumulation of CD150 hi Flt3 − CD34 − LT-HSClike cells (Supplementary Fig. 4d-g ). These results further support in vivo the idea of a role for antagonistic interaction between the ubiquitin ligase Fbw7 and substrate in the differentiation and selfrenewal capacity of HSCs.
Abundance of c-Myc controls the molecular program of HSCs
To further understand the mechanistic effect of c-Myc protein stabilization in HSCs, we purified c-Myc-eGFP hi and c-Myc-eGFP lo subsets and used whole-genome transcriptome analysis to define the gene-expression signatures of each population. A substantial alteration in the gene-expression program accompanied the transition from c-Myc-eGFP lo to c-Myc-eGFP hi (Fig. 4a) (Fig. 4a) , which emphasizes the close biological connection between the two molecules and further explains the loss of self-renewal capacity of Fbw7 −/− HSCs. Further studies with the Gene Set Enrichment Analysis (GSEA) tool 27 provided additional information about gene clusters shared by the c-Myc-eGFP lo and c-Myc-eGFP hi signature and publicly available data sets. There was a sizable correlation between the c-Myc-eGFP lo gene signature and several published HSC-related data sets (Fig. 4b) . Conversely, data sets presenting genes encoding molecules that A r t i c l e s that positively control cell-cycle progression, DNA replication and c-Myc-induced genes in various cell types showed substantial enrichment for the c-Myc-eGFP hi signature [28] [29] [30] . Similarly, analysis of the Kyoto Encyclopedia of Genes and Genomes pathway and the Database for Annotation, Visualization, and Integrated Discovery showed substantial enrichment for genes associated with the cell cycle, DNA replication and metabolism in the c-Myc-eGFP hi population (data not shown). Notably, further GSEA showed substantial enrichment for genes regulated by the transforming growth factor-β and Wnt-β-catenin pathways in the c-Myc-eGFP lo signature ( Fig. 4c and Supplementary Fig. 5 ). Both pathways have been linked to the regulation of HSC differentiation and self-renewal 31, 32 . These studies correlate the abundance of a single transcription factor to the geneexpression signature that defines HSC quiescence and self-renewal.
Identification of genes directly controlled by c-Myc
The results reported above are of unique importance, as they suggest that the stability of c-Myc protein is a central regulator of gene-expression programs that influence HSC self-renewal, transcription and cell-cycle entry. To further explore the mechanism of c-Myc-controlled gene regulation, we compared the identified microarray signatures to our whole-genome ChIP-plus-microarray data sets containing loci occupied by c-Myc factors in c-Myc-expressing leukemia cells (T-ALL cells) 33 . This comparison demonstrated substantial enrichment of genes overexpressed in the c-Myc-eGFP hi subset in the T-ALL ChIP-plus-microarray data set (Fig. 5a) . Most of these genes also belonged to functional categories related to cell-cycle progression, transcription, translation and epigenetic control ( Fig. 5 and Supplementary Fig. 6 ). To demonstrate the validity of these whole-genome-wide ChIP-plus-microarray studies, we selected ten genes suggested to be important in the regulation of cell-cycle progression, gene translation and transcription. Using this model-gene subset, we did conventional ChIP. As predicted, the c-Myc-binding sites on the promoters of all these genes were indeed occupied by the c-Myc factor (Fig. 5b) .
As the database presented here was generated with human c-Mycexpressing hematopoietic tumor (leukemia) cells, we sought to further confirm these results with mouse c-Kit-expressing stem and progenitor cells. We were able to demonstrate that the genes bound by c-Myc noted above (Fig. 5b) were also transcriptionally regulated by c-Myc in bone marrow HSCs and progenitor cells (Fig. 5b,c and Supplementary Fig. 7 ). These genes were expressed in wildtype HSCs, had high expression in the c-Myc-eGFP hi subset and were silenced in HSCs purified from compound Myc −/− mice (with deletion of Myc and Mycn, which encodes n-Myc) 16 . To further rule out the possibility that our present findings were biased because of the ChIP database used, we selected a group of genes overexpressed in the c-Myc-eGFP hi LSK subset that also have putative c-Myc-binding sites highly conserved between mice and humans. We did conventional ChIP with highly purified bone marrow Lin − c-Myc-eGFP hi progenitors and found that a substantial portion of these gene promoters were indeed bound by c-Myc factors (Fig. 5c) . Collectively, these studies demonstrate a mechanistic correlation among c-Myc protein abundance, binding on regulatory DNA sites and transcriptional control of HSC differentiation.
Fbw7-c-Myc axis in fetal liver hematopoietic cells
We next sought to test the importance of c-Myc stability in a stem cell population closely related to adult HSCs: fetal liver HSCs. Although they are phenotypically and functionally very similar to adult HSCs, fetal HSCs actively expand in number in the fetal liver during embryonic days 12.5-14.5 (E12.5-E14.5) 34 . Thus, we hypothesized that fetal HSCs would have more c-Myc protein than their adult counterparts. Our results confirmed our hypothesis (Fig. 6) . Initially, almost threefold more fetal LSK cells were in cycle at any given moment, in agreement with published data (Fig. 6b) . Also, the abundance of c-Myc protein was substantially greater in fetal total LSK cells and CD150 + LSK cells (in E13.5-14.5 Myc eGFP/+ embryos) than in adult LSK cells (Fig. 6c-d) .
Notably, in vitro colony-forming unit assays with purified c-MyceGFP hi and c-Myc-eGFP lo fetal HSCs showed no difference in the ability to generate hematopoietic colonies in primary, secondary or tertiary plating assays (Fig. 6e) . These findings were consistent with transcriptome studies showing very similar gene-expression signatures 
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in the c-Myc-eGFP hi and c-Myc-eGFP lo fetal LSK subsets, in contrast to the well-defined and largely distinct signatures of their adult counterparts ( Fig. 6e and Supplementary  Fig. 8 ). However, long-term competitive reconstitution assays with the fetal liver c-Myc-eGFP hi and c-Myc-eGFP lo LSK subsets demonstrated that when introduced into an adult environment, c-Myc-eGFP hi cells were unable to produce long-term chimerism, in agreement with the results obtained with their adult counterparts (Fig. 6f) .
Dynamic regulation of Fbw7 and c-Myc in ESCs
To further probe the universality of the Fbw7-c-Myc interaction in stem cell self-renewal, we turned to the study of ESCs, a stem cell type with properties fundamentally distinct from those of adult and quiescent HSCs. ESCs are unique among stem cells as they can differentiate into all three germ layers and self-renew extensively in culture 35 . In terms of cell-cycle regulation, ESCs proliferate rapidly, show a shortened G1 phase and have constitutively active cyclin E (CDK2). Furthermore, ESCs have low expression of the D-type cyclins and have almost no CDK4 kinase activity 36 . We were thus tempted to suggest that Fbw7 could be dispensable for the self-renewal of ESCs. Indeed, our initial expression studies supported this idea, as Fbw7 had lower expression in self-renewing ESCs and was upregulated as differentiation was induced (Fig. 7a) . To further prove the results of those quantitative PCR studies, we used a trapped ESC line in which a lacZ reporter cassette was introduced in the Fbw7 locus, disrupting expression monoallelically (Fig. 7b) . Expression of the Fbw7 locus containing the lacZ reporter cassette was almost undetectable in self-renewing ESCs and was subsequently induced after ESC differentiation (Fig. 7c) . Although there were minimal differences between (Fig. 7a) , c-Myc protein expression was readily detectable in self-renewing ESCs and became downregulated after induction of differentiation (Fig. 7d) , which confirmed the results of many published studies connecting c-Myc expression to ESC pluripotency 37, 38 . ChIP studies showed that c-Myc was not only expressed but also detectable on the promoters of selected predicted gene targets (Fig. 7e) .
Fbw7 is dispensable for the self-renewal of ESCs
To address whether c-Myc stability could also be regulated by the ubiquitin-proteasome system in ESCs, we treated self-renewing and differentiating ESCs with the proteasome inhibitor MG132. We found A r t i c l e s that both total and phosphorylated c-Myc protein accumulated in both self-renewing and differentiating culture conditions (Fig. 7d) .
Complementary to that finding, we also treated Myc eGFP/+ ESCs with MG132 and observed stabilization of c-Myc-eGFP by flow cytometry as well as by immunofluorescence with an antibody that detects eGFP (Fig. 8a,b) . To begin to assess the role of Fbw7 in ESC self-renewal and its regulation of c-Myc, we used gene silencing mediated by small interfering (siRNA). ESC cell-specific knockdown of Fbw7 resulted in the accumulation of c-Myc-eGFP (Fig. 8c) , which suggested that Fbw7 regulates the stability of c-Myc protein in self-renewing ESCs. Knockdown of Fbw7 was very efficient, as measured by quantitative PCR (Fig. 8d) . We obtained similar results with another mouse ESC line (W4) using short hairpin (shRNA) specific for Fbw7, in which knockdown resulted in the accumulation of both total and phosphorylated c-Myc protein (Fig. 8e) . However, there were no phenotypic changes (Fig. 8f) or changes in expression of germline markers, which demonstrated that ESCs retain characteristics associated with the molecular effects of ESC self-renewal (data not shown). In contrast, silencing of Nanog, which encodes a pluripotency regulator, led to rapid cell differentiation and loss of self-renewal (Fig. 8f) .
To further assess the dispensability of Fbw7 in ESCs, at least in this in vitro system, we used a transgenic ESC line that reports selfrenewal because of the expression of GFP driven by Nanog regulatory elements 39 . Fbw7 silencing was unable to affect Nanog-GFP expression and ESC self-renewal in this system (Fig. 8g) . Overall, these observations show that Fbw7 expression is upregulated during ESC differentiation and that Fbw7 silencing is dispensable for the in vitro self-renewal of ESCs. They also identify a substantial molecular distinction between ESCs and quiescent adult stem cells (HSCs; Supplementary Fig. 9 ).
DISCUSSION
Our observations have identified a specific ubiquitin ligase-substrate pair as a central regulator of stem cell differentiation. We have demonstrated in vivo that slight changes in the stability and abundance of c-Myc protein expression had the role of a rheostat controlling adult stem cell quiescence and self-renewal. Our work has also explained the mechanism by which c-Myc carries out its function in the HSC population. We have identified, by whole-genome transcriptional analysis and ChIP-plus-microarray approaches, a constellation of genes directly regulated by the relative abundance of this transcription factor during these early stages of hematopoiesis. Most notably, our studies suggest differences between adult stem cells and ESCs in the need for c-Myc stability, which suggests that different stem cell types sense and interpret c-Myc-regulated gene expression in distinct ways. All of our studies prove the hypothesis that the ubiquitin-proteasome system can control stem cell differentiation by directly controlling important regulators of cell-cycle entry, self-renewal and/or lineage commitment. Further studies are needed to define the extent of the involvement of the ubiquitin system in different aspects of stem and progenitor cell biology. Our findings explain the discrepancy between Myc mRNA expression and function that has been demonstrated before. Indeed, c-Mycdeletion studies have suggested that c-Myc expression is essential for the exit of HSCs from the osteoblastic niche by regulating the expression of essential adhesion molecules, including N-cadherin 17 . However, those same investigators have shown that Myc mRNA stability remains stable from the LT-HSC stage to the common myeloid progenitor stage, which calls into question the HSC-specific function of this transcription factor 16 . Those findings were verified by our own independent analysis. We have demonstrated here that Fbw7 expression was high at the LT-HSC stage and was almost undetectable at subsequent MPP and myeloerythroid progenitor stages of differentiation. Similarly, c-Myc protein abundance increased as HSCs differentiated and reached its peak at the myeloerythroid progenitor and common myeloid progenitor stages. These observations explain the reported discrepancy and emphasize the importance of ubiquitinmediated protein stability in these early stages of hematopoiesis.
We have also demonstrated a difference in the dependence of ESCs and adult HSCs on c-Myc stability and Fbw7 activity. Indeed, adult HSCs were characterized by high Fbw7 expression and rapid c-Myc turnover, whereas self-renewing ESCs demonstrated only basal Fbw7 activity and very stable c-Myc protein. Few such factors with distinct functions in the two stem cell types have been identified thus far, most of them being members of the machinery that initiates the cell cycle, including cyclin D and cyclin E, cell-cycle inhibitors (CDKI) and retinoblastoma protein (pRb). The differences in Fbw7 expression are probably tightly linked to the cell cycle-entry machinery. Indeed, studies of embryonic fibroblasts have shown that Fbw7 expression is cell cycle dependent, with the highest expression recorded at the G0-G1 stages (B.A.-O. and I.A., unpublished observations). The Fbw7 activity during ESC differentiation is consistent with c-Myc availability and its essential role in the regulation of pluripotency; however, at this point, we cannot exclude the possibility of a role for additional ESC Fbw7 substrates that could control cell-cycle progression, including cyclin E. Finally, as c-Myc has been proven to be one of the factors that control adult cell reprogramming 38 , we propose that the ubiquitin system and more specifically Fbw7 could be a key regulator of this process. Our data also fit perfectly with other studies showing that the kinase GSK3β, which phosphorylates c-Myc on Thr58 and triggers Fbw7-mediated degradation in other cell systems 40 , is largely excluded from the nucleus in self-renewing ESCs. GSK3β enters the nucleus after ESC differentiation because of the absence of activation of the kinase Akt induced by the cytokine LIF 41 . We have demonstrated here that both proteasome inhibition and Fbw7 knockdown led to stabilization and overexpression of c-Myc phosphorylated on Thr58, which connects ESC differentiation, kinase activation, recruitment of the Fbw7 complex and c-Myc degradation.
Our work has also suggested that the ubiquitin complex is a regulator of stem cell differentiation and function. Indeed, the activity of ubiquitin ligases (such as Fbw7) or opposing deubiquitinases could control both the abundance and activation of central stem cell regulators. This close connection seems to be conserved among species, as a report has shown a requirement for the deubiquitinase Scrawny in the epigenetic control of gene expression in Drosophila melanogaster stem cells 10 . All these observations propose an additional layer of stem cell regulation and also suggest that genetic or chemical targeting of specific ubiquitin enzyme activity could affect somatic cell reprogramming, adult stem cell population expansion and, putatively, cancer stem cell differentiation and oncogenicity.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Accession codes. GEO: microarray data, GSE19502.
Treatment with 5-FU. Experiments with 5-FU were done as described 16 . Myc eGFP/− mice were injected one time with 75 µg fluorouracil per gram body weight and the LSK population in the bone marrow was analyzed 2 d after treatment by flow cytometry.
Statistical analysis. An unpaired two-tailed Student's t-test with assumption of experimental samples of equal variance was used for all statistical analyses, unless otherwise specified.
